Recall Record

Hawthorne, NY, United States

Taro Pharmaceuticals U.S.A., Inc. recalls

11 recalls recorded since 2018, most recently on 7 August 2024. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls11
Ongoing (FDA)0
Terminated or completed11
Class I (FDA)3

Completed Class III Drugs

Recall started
7 August 2024
Reason
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Distribution
Product was distributed to one distributor
Initiated
Voluntary: Firm initiated
Recall number
D-0633-2024

Terminated Class III Drugs

Recall started
25 February 2022
Terminated
9 September 2024
Reason
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
Distribution
Product was distributed to one retail consignee in NY.
Initiated
Voluntary: Firm initiated
Recall number
D-0727-2022

Terminated Class I Drugs

Recall started
15 December 2021
Terminated
4 December 2023
Reason
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Distribution
Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0375-2022

Terminated Class II Drugs

Recall started
8 January 2021
Terminated
7 September 2023
Reason
CGMP deviations.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0246-2021

Terminated Class II Drugs

Recall started
17 November 2020
Terminated
21 February 2024
Reason
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Distribution
Distributed Nationwide in the USA and Canada
Initiated
Voluntary: Firm initiated
Recall numbers
D-0154-2021, D-0158-2021, D-0156-2021, D-0155-2021, D-0150-2021, D-0159-2021, D-0157-2021, D-0153-2021, D-0151-2021, D-0152-2021

Terminated Class III Drugs

Recall started
20 July 2020
Terminated
20 June 2023
Reason
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Distribution
Nationwide in the U.S.
Initiated
Voluntary: Firm initiated
Recall number
D-1496-2020

Terminated Class I Drugs

Recall started
7 February 2020
Terminated
11 December 2023
Reason
Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.
Distribution
Distributed Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0863-2020

Terminated Class I Drugs

Recall started
20 December 2019
Terminated
23 February 2024
Reason
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Distribution
Nationwide in the U.S. and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
D-0833-2020

Terminated Class II Drugs

Recall started
27 September 2019
Terminated
31 August 2023
Reason
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0299-2020, D-0301-2020, D-0298-2020, D-0302-2020, D-0300-2020

Terminated Class II Drugs

Recall started
19 October 2018
Terminated
3 November 2020
Reason
Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0277-2019, D-0278-2019, D-0276-2019

Terminated Class III Drugs

Recall started
21 December 2017
Terminated
21 September 2020
Reason
Failed Content Uniformity Specifications
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0249-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.